Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols / BRSCW Applicant: Diamandis - Mt Sinai (2006)

BRSCW Applicant: Diamandis - Mt Sinai (2006)

283
KLKs 5,6,7,8,10,11
Case/control
Proteomics
Breast and Gynecologic Cancers Research

Examine kallikreins as ovarian cancer biomarkers and determine sensitivity and specificity of panel

Determine sensitivity and specificity of a panel of kallikreins for early ovarian cancer diagnosis
ELISA assays
An oral presentation by Dan Cramer was given at the 2009 AACR annual meeting

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.


Announcement 09/14/2014

Thank you to everyone who helped make the 9th EDRN Scientific Workshop a success. We look forward to seeing everyone at the 28th EDRN Steering Committee Meeting from March 31-April 2, 2015, in Atlanta, GA.

Announcement 06/05/2014


Funding Opportunity Available

Both RFAs for Molecular and Cellular Characterization of Screen-Detected Lesions have been published.

RFA-CA-14-010.html

and

RFA-CA-14-011.html